Security
ENLV · Enlivex Ltd.
ENLVNASDAQCommon stockCurrentCIK 1596812Updated Sep 26, 2026
Name history
Enlivex Therapeutics Ltd. · through Feb 10, 2026Bioblast Pharma Ltd. · through Mar 18, 2019BIO BLAST PHARMA LTD. · through Sep 12, 2016
ENLV price & chart
Loading TradingView…
NASDAQ:ENLV on TradingView ↗About the company
Enlivex is a quality longevity company powered by a prediction markets treasury. The Company is advancing Allocetra™, an advanced clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with a primary focus on age-related osteoarthritis. In addition to its clinical programs, Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem.
In the news
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 2,326,998,000Source | 27,687,000Source | 36,831,000Source | 67,642,000Source |
| Property, Plant and Equipment, NetUSD | 361,000Source | 625,000Source | 1,539,000Source | 9,875,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,894,000Source | 3,301,000Source | 813,000Source | 49,945,000Source |
| Assets, CurrentUSD | 1,743,178,000Source | 25,993,000Source | 33,764,000Source | 52,330,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 4,361,000Source | 2,299,000Source | 1,336,000Source | 2,086,000Source |
| Operating Lease, Right-of-Use AssetUSD | 577,000Source | 528,000Source | 1,041,000Source | — |
| Other Assets, NoncurrentUSD | 951,000Source | 1,069,000Source | 1,528,000Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 392,050,000Source | 4,098,000Source | 6,747,000Source | 10,801,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 28,730,000Source | 2,685,000Source | 2,137,000Source | 2,117,000Source |
| Additional Paid in CapitalUSD | 796,696,000Source | 146,910,000Source | 138,939,000Source | 136,648,000Source |
| Retained Earnings (Accumulated Deficit)USD | 1,108,421,000Source | -127,107,000Source | -112,093,000Source | -83,025,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 1,101,000Source | 1,101,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 1,934,948,000Source | 23,589,000Source | 30,084,000Source | 56,841,000Source |
| Liabilities and EquityUSD | 2,326,998,000Source | 27,687,000Source | 36,831,000Source | 67,642,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 9,021,000Source | 3,799,000Source | 6,061,000Source | 6,607,000Source |
| Operating Lease, Liability, CurrentUSD | — | 235,000Source | 346,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 383,000Source | 299,000Source | 686,000Source | — |
| Deferred Income Tax Liabilities, NetUSD | 382,646,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | — | 299,000Source | 686,000Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 5,213,000Source | 2,846,000Source | 4,001,000Source | — |
| Deferred Tax Liabilities, NetUSD | 382,646,000Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,783,000Source | 2,065,000Source | 1,951,000Source | 2,712,000Source |
| Deferred Income Tax Expense (Benefit)USD | 382,646,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -10,416,000Source | -13,008,000Source | -23,523,000Source | -23,953,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,323,000Source | 9,059,000Source | -25,968,000Source | 62,524,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 68,000Source | 103,000Source | 236,000Source | 8,122,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 10,381,000Source | 6,454,000Source | 360,000Source | 150,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,373,000Source | 3,731,000Source | 1,226,000Source | 50,357,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,141,000Source | 1,475,000Source | 1,565,000Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 1,783,000Source | 2,065,000Source | 1,951,000Source | — |
| DepreciationUSD | 332,000Source | 545,000Source | 835,000Source | 777,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | 1,268,084,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | 1,149,000Source | -182,000Source | -1,224,000Source | — |
| Gain (Loss) on Disposition of AssetsUSD | 363,191,000Source | — | — | — |
| Gain (Loss) on InvestmentsUSD | 310,124,000Source | — | — | — |
| Gain (Loss) on Disposition of Other AssetsUSD | -29,000Source | -957,000Source | -4,244,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 1,000Source | 82,000Source | 20,000Source | — |
| General and Administrative ExpenseUSD | 5,796,000Source | 4,913,000Source | 6,139,000Source | 7,104,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -1,235,528,000Source | 15,014,000Source | 29,068,000Source | 31,060,000Source |
| Income Tax Expense (Benefit)USD | 382,646,000Source | — | — | — |
| Investment Income, InterestUSD | 792,000Source | 1,069,000Source | 1,565,000Source | 835,000Source |
| Marketable Securities, Unrealized Gain (Loss)USD | — | 0Source | 0Source | -1,983,000Source |
| Net Income (Loss) Attributable to ParentUSD | 1,235,528,000Source | -15,014,000Source | -29,068,000Source | -31,060,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 31,060,000Source |
| Nonoperating Income (Expense)USD | 1,928,000Source | — | — | — |
| Operating ExpensesUSD | 15,029,000Source | 15,888,000Source | 29,395,000Source | 25,797,000Source |
| Operating Lease, ExpenseUSD | 316,000Source | 324,000Source | 863,000Source | 1,037,000Source |
| Other Nonoperating Income (Expense)USD | 1,928,000Source | 874,000Source | 327,000Source | -5,263,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | 513,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | 150,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | 363,191,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -15,029,000Source | -15,888,000Source | -29,395,000Source | -25,797,000Source |
| Other Nonoperating Income (Expense)USD | 1,928,000Source | 874,000Source | 327,000Source | -5,263,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 1,618,174,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 382,646,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | 1,235,528,000Source | -15,014,000Source | -29,068,000Source | -31,060,000Source |
| Earnings Per Share, BasicUSD per share | 27.04Source | -0.73Source | -1.56Source | -1.69Source |
| Earnings Per Share, DilutedUSD per share | 25.48Source | -0.73Source | -1.56Source | -1.69Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 45,696,208Source | 20,513,992Source | 18,574,484Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 48,498,891Source | 20,513,992Source | 18,574,484Source | — |
| Additional Financial Items | ||||
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | 1,268,084,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | 1,149,000Source | -182,000Source | -1,224,000Source | — |
| Gain (Loss) on InvestmentsUSD | 310,124,000Source | — | — | — |
| General and Administrative ExpenseUSD | 5,796,000Source | 4,913,000Source | 6,139,000Source | 7,104,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -1,235,528,000Source | 15,014,000Source | 29,068,000Source | 31,060,000Source |
| Investment Income, InterestUSD | 792,000Source | 1,069,000Source | 1,565,000Source | 835,000Source |
| Labor and Related ExpenseUSD | 859,000Source | 831,000Source | 912,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 31,060,000Source |
| Nonoperating Income (Expense)USD | 1,928,000Source | — | — | — |
| Operating ExpensesUSD | 15,029,000Source | 15,888,000Source | 29,395,000Source | 25,797,000Source |
| Operating Lease, ExpenseUSD | 316,000Source | 324,000Source | 863,000Source | 1,037,000Source |
| Other ExpensesUSD | 29,000Source | 352,000Source | — | 707,000Source |
| Other General and Administrative ExpenseUSD | 186,000Source | 232,000Source | 471,000Source | — |
| Research and Development ExpenseUSD | 9,204,000Source | 10,623,000Source | 19,012,000Source | 18,693,000Source |
Filing attachments
ea030609201ex99-1.htm · 6-K · 2026-09-22
Exhibit 99.1 Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens Nes-Ziona, Israel, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) (“Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced the termination of a securities purchase agreement entered into with the Rain Foundation, pursuant to which the Company had agreed, subject to shareholder approval, to sell and issue to the Rain Found…
Read attachment ↗